Follicular lymphoma

A Carbone, S Roulland, A Gloghini, A Younes… - Nature reviews Disease …, 2019 - nature.com
Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal
centre (GC) B cell differentiation. FL represents~ 5% of all haematological neoplasms and …

Follicular lymphoma: 2020 update on diagnosis and management

A Freedman, E Jacobsen - American journal of hematology, 2020 - Wiley Online Library
Disease overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is …

Follicular lymphoma: 2023 update on diagnosis and management

E Jacobsen - American Journal of Hematology, 2022 - Wiley Online Library
Abstract Disease Overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

[HTML][HTML] Involved site radiation therapy in adult lymphomas: an overview of International Lymphoma Radiation Oncology Group guidelines

A Wirth, NG Mikhaeel, BMP Aleman, CC Pinnix… - International Journal of …, 2020 - Elsevier
Involved node radiation therapy for lymphoma was introduced with the aim of using the
smallest effective treatment volume, individualized to the patient's disease distribution, to …

Tumor response to radiopharmaceutical therapies: the knowns and the unknowns

G Sgouros, YK Dewaraja, F Escorcia… - Journal of Nuclear …, 2021 - jnm.snmjournals.org
Radiopharmaceutical therapy (RPT) is defined as the delivery of radioactive atoms to tumor-
associated targets. In RPT, imaging is built into the mode of treatment since the …

Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors

JG Schroers-Martin, J Soo, G Brisou, F Scherer… - Cancer discovery, 2023 - AACR
Follicular lymphomas (FL) are characterized by BCL2 translocations, often detectable in
blood years before FL diagnosis, but also observed in aging healthy individuals, suggesting …

The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma

SF Barrington, J Trotman - The Lancet Haematology, 2021 - thelancet.com
This Review focuses on the use of 18 F-fluorodeoxyglucose (18 F-FDG) PET in the
assessment of diffuse large B-cell lymphoma, follicular lymphoma, and peripheral T-cell …

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

GT Los-de Vries, WBC Stevens, E van Dijk… - Blood …, 2022 - ashpublications.org
Although the genomic and immune microenvironmental landscape of follicular lymphoma
(FL) has been extensively investigated, little is known about the potential biological …

Response-adapted ultralow-dose radiation therapy for orbital indolent B-cell lymphoma: A phase 2 nonrandomized controlled trial

CC Pinnix, BS Dabaja, JR Gunther, PQ Fang… - JAMA …, 2024 - jamanetwork.com
Importance Radiation therapy to doses of 24 to 36 Gy is currently used to treat indolent B-
cell lymphoma of the ocular adnexa; however, ocular adverse effects are common. Objective …

[68Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas

SS Mahase, DA Roth O'Brien, D No… - Neuro-oncology …, 2021 - academic.oup.com
Background Meningiomas express high levels of somatostatin receptor 2 (SSTR2). SSTR2-
targeted PET imaging with [68Ga]-DOTATATE can aid with distinguishing residual …